Pharmacogenomics

Article	Citations
Effects of SLCO1B1 on Elimination and Toxicities of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia	32
Association of OPRK1 rs963549 and rs997917 Polymorphisms With Opioid Use Disorder and Related Phenotypes	23
Implication of KDM6A in Bladder Cancer	23
Pharmacogenomics of Medications Given Via Nonconventional Administration Routes: A Scoping Review	21
HLA Pharmacogenetic Markers of Drug Hypersensitivity from the Perspective of the Populations of the Greater Middle East	20
Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention	20
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability	19
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress	19
Highlights of 2022 and Looking Forward to 2023 at Pharmacogenomics	18
Association of IL4RA Polymorphism in Predicting Susceptibility Toward Chronic Obstructive Pulmonary Disease	16
Pilot Study of Multi-Gene Pharmacogenetic Testing for Pain Management in Oncology Palliative Medicine	15
Update on the PriME-PGx initiative: evolution of pharmacogenetics in daily clinical practice	14
Correlation of ACE insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients	14
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients	14
Negative Symptoms in Schizophrenia: Correlation with Clinical and Genetic Factors	12
Analysis of the Difference in SLCO1B1 and APOE Gene Polymorphisms Between Mongolian and Han Populations	11
Glutathione S -transferase Gene Polymorphism and Asthma: A Case–Control Study in a Pediatric Population	11
Patients’ Perspectives of a Pharmacist-Provided Clinical Pharmacogenomics Service	11
Circulating Tumor DNA-Guided Minimal Residual Disease Assessment in Colorectal Cancer	11
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing	10
Use of a Consultation Service Following Pharmacogenetic Testing in Psychiatry	10
Molecular Pathogenesis of Hereditary Lung Cancer: a Literature Review	10
Poly(ADP-ribose) Polymerase Inhibitors in Prostate Cancer: A Cornerstone in Precision Oncology	10
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review	10
Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel	10

Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema	10
Is there Benefit for Cyp2C19 Genotype-Guided Antiplatelet Treatment in Elderly Acute Coronary Syndrome Patients?	9
The Need for a Refined Understanding of CYP2D6 in Second-Generation Antipsychotic Outcomes in Children and Adolescents	9
Genetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What do we Know?	9
Therapy Response Prediction in Major Depressive Disorder: Current and Novel Genomic Markers Influencing Pharmacokinetics and Pharmacodynamics	9
Transcriptional Effects of Fingolimod Treatment on Peripheral T Cells in Relapsing Remitting Multiple Sclerosis Patients	8
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations	8
Impact of IL-6 and IL-10 genotypes on tacrolimus dose requirements in kidney transplant recipients: Monte Carlo analysis	8
NAT2 Polymorphism and Clinical Factors that Increase Antituberculosis Drug-Induced Hepatotoxicity	8
Retrospective Pharmacogenetic Study in a Cohort of Pediatric Tuberous Sclerosis Complex Patients Using Everolimus	8
Genetic Variants of the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Reaction Element Pathway on the Risk of Antituberculosis Drug-Induced Liver Injury: A Systematic Review	8
Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty	8
Pharmacoepigenomics: A Key Determinant in Resolving Epigenomic Parameters in Pathogenesis and Treatment Response in Complex Diseases	8
Correlation between Methylation Level of the SLC19A1 Promoter Region and Methotrexate Metabolism in Adult Acute Lymphoblastic Leukemia	8
Challenges for the Application of Pharmacogenomics Associated with the Nomenclature of Allelic Variants	8
PGxKnow: A Pharmacogenomics Educational Hololens Application of Augmented Reality and Artificial Intelligence	7
Pharmacogenomic Testing to Support Prescribing in Primary Care: a Structured Review of Implementation Models	7
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing	7
Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism	7
Erratum	7
The Effects of Sex on Pharmacogenetically Guided Drug Treatment	7
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization	7
Epigenetic Regulation of Drug Metabolism in Aging: Utilizing Epigenetics to Optimize Geriatric Pharmacotherapy	7
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study	7
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation	7
Pharmacogenomics in Sri Lanka: a comprehensive systematic review of the research landscape and clinical implications	6
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations	6
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review	6
CYP2C18: The Orphan in the CYP2C Family	6
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada	6
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison	6
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications	6
Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases	6
Update on HLA-B*15:02 Allele Associated with Adverse Drug Reactions	6
Patient perspectives of a multidisciplinary Pharmacogenomics clinic	6
Influence of Genetic Variants on the Pharmacokinetics and Pharmacodynamics of Sirolimus: A Systematic Review	6
PMAT Variant Rs3889348 is Associated with Metformin-Induced Gastrointestinal among Chinese Type 2 Diabetes Patients	6
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?	6
XDH Genotypes Through Gene–Gene Interactions with NUDT15 Affect Azathioprine-Induced Leukopenia in Chinese Patients	5
Are There Monogenic Hereditary Forms of Bladder Cancer or Only Genetic Susceptibilities?	5
Changing from Mandatory to Optional Genotyping Results in Higher Acceptance of Pharmacist-Guided Warfarin Dosing	5
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report	5
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates	5
Keeping Pace with CYP2D6 Haplotype Discovery: Innovative Methods to Assign Function	5
Implementing pharmacogenomic testing in Australian general practice: an exploratory qualitative study	5
Single-Nucleotide Polymorphism Associations with Efficacy and Toxicity in Metastatic Castration-Resistant Prostate Cancer Treated with Cabazitaxel	5
Establishment of a Prediction Algorithm for the Honghe Minority Group Based on Warfarin Maintenance Dose	5
Pharmacogenomics of Chloroquine and Hydroxychloroquine: Current Evidence and Future Implications	5
Pharmacogenetic Testing-Guided Treatment for Oncology: An Overview of Reviews	4
Pharmacogenetic Evaluation of 6-Mercaptopurine-Mediated Toxicity in Pediatric Acute Lymphoblastic Leukemia Patients from a South Indian Population	4

Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities	4
A Meta-Analysis of Effects of Cyp2C9 and Cyp2C19 Polymorphisms on Phenytoin Pharmacokinetic Parameters	4
The Frequency of Rs2231142 in ABCG2  among Asian Subgroups: Implications for Personalized Rosuvastatin Dosing	4
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level	4
Pharmacogenomics in Pediatric Medicine and Drug Development	4
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study	4
Impact of Genetic Polymorphisms on Tacrolimus Trough Blood Concentration in Chinese Liver Transplant Recipients	4
The Importance of Including African Populations in Pharmacogenetics Studies of Warfarin Response	4
Genetic profiling of NUDT15 in the Slovenian population	4
Effects of Genetic Polymorphisms of ABCB1 on the Efficacy of Anesthetic and Analgesic Agents: a Systematic Review	4
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis	4
Pharmacogenomics Implementation Across Multiple Clinic Settings: A Qualitative Evaluation	4
Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy	4
Genome-Wide Association Study of Liver Enzyme Elevation in Rheumatoid Arthritis Patients Starting Methotrexate	4
Rapid point of care testing: the next frontier in pharmacogenomics	4
Genetic Variants of Pear1 and Ischemic Clinical Outcomes in Coronary Artery Disease Patients: a Systematic Review and Meta-Analysis	4
Pharmacogenetics of Pain Management in Zimbabwean Patients With Sickle Cell Disease	4
Polymorphisms in the CYP3A5 Gene Significantly Affect the Pharmacokinetics of Sirolimus After Kidney Transplantation	4
HLA-A*24:07 as a Potential Biomarker for Carbamazepine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Filipino Patients	4
Effects of Oxycodone Pharmacogenetics on Postoperative Analgesia and Related Clinical Outcomes in Children: A Pilot Prospective Study	4
Personalized Anti-Rejection Therapy with Alemtuzumab for Kidney Transplant Recipients	4
Overview of the Year 2023 at Pharmacogenomics	3
Pharmacogenomic Landscape of Covid-19 Therapies From Indian Population Genomes	3
Premarket Assessment of Molecular Alterations in Drug Targets: A Case Study of 2020 Drug Approvals	3
Tabula Rasa Healthcare Company Profile: Involvement in Pharmacogenomic and Personalized Medicine Research	3
The pharmacogenetics of treatment with olanzapine	3
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients	3
Characterization of POR Haplotype Distribution in African Populations and Comparison with Other Global Populations	3
Systematic Review of Pharmacogenomics Knowledgebase Evidence for Pharmacogenomic Links to the Dopamine Reward Pathway for Heroin Dependence	3
Interethnic Differences in Drug Response: Projected impact of Genetic Variations in the Saudi Population	3
A Survey of Physician Opinions in Russia in the Field of Pharmacogenetics of Cardiovascular Disease	3
Diagnosis and Treatment Monitoring in Breast Cancer: How Liquid Biopsy Can Support Patient Management	3
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward	3
Could Pharmacogenetics Aid the Prediction of NeviRapine Pharmacokinetics and Allow Individualized Treatment?	3
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message	3
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants	3
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?	3
Genetic Variability of CYP2D6, CYP3A4 and CYP3A5 Among the Egyptian Population	3
Evidence of Pharmacogenetics-Based Fluvoxamine Use as an Add-On to Clozapine Treatment in Psychiatry	3
Impact of Pharmacogenomics in Achieving Personalized/Precision Medicine in the Clinical Setting: A Symposium Report	3
Advancing pharmacogenomics research: automated extraction of insights from PubMed using SpaCy NLP framework	3
Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients	3
Whole-exome Sequencing Reveals Novel Candidate Single Nucleotide Variations for Preventing Adverse Effects of Levonorgestrel Implantation	3
Application of the Community Dialogues Method to Identify Ethical Values and Priorities Related to Pharmacogenomics	3
Precision Medicine in Interventional Cardiology: Implications for Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention	3
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites	3
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy	3
Effects of MDR1 and OPRM1 Genetic Polymorphisms on the Pharmacodynamics of Propofol–Remifentanil TIVA in Pediatrics	3
Exploring Pharmacogenetic Variants for Predicting Response to Anti-TNF Therapy in Autoimmune Diseases: a Meta-Analysis	3
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms	3
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro	3
Pharmacogenomic Markers of Metoprolol and α-OH-Metoprolol Concentrations: A Genome-Wide Association Study	2
Bioinformatic Tools are Essential to Integrating Pharmacogenomics into Clinical Practice: Lessons from Neuropsychiatric Disorders	2
IL16 and Factor V Gene Variations are Associated with Asparaginase-Related Thrombosis in Childhood Acute Lymphoblastic Leukemia Patients	2
Implementation of a Next-Generation Sequencing-Based Targeted Approach for Full-Length CYP3A4 Gene Sequencing	2
Role of the Preoperative Circulating Tumor DNA KRAS Mutation in Patients With Resectable Pancreatic Cancer	2
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?	2
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis	2
CYP2C19 and CES1 gene variants affecting clopidogrel metabolism in a South Asian population from Sri Lanka	2
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study	2
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories	2
Effect of UGT Polymorphisms on Pharmacokinetics and Adverse Reactions of Mycophenolic Acid in Kidney Transplant Patients	2
SLCO1B3 T334G Polymorphisms and Mycophenolate Mofetil-Related Adverse Reactions in Kidney Transplant Recipients	2
Towards Next-Generation Personalization of Tacrolimus Treatment: a Review on Advanced Diagnostic and Therapeutic Approaches	2
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study	2
Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor	2
Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital	2
Resistance to Platinum-Based Cancer Drugs: a Special Focus on Epigenetic Mechanisms	2
Pharmacogenetics Research in Brazil: A Systematic Review	2
Gut Microbiota and Treatment-Resistant Schizophrenia: Many Questions, Fewer Answers	2
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions	2
Screening and analysis of single nucleotide polymorphism in the 3′-UTR microRNA target regions and its implications for lung tumorigenesis	2
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel	2
Sertraline Dosing Trends in Children and Adolescents Stratified by CYP2C19 Genotype	2
An Alcohol Dehydrogenase 7 Gene Polymorphism Associates with Both Acute and Chronic Pain in Sickle Cell Disease	2
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration	2
Effect of Pharmacogenomic Testing on Pediatric Mental Health Outcome: A 6-Month Follow-Up	2
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing	2
UGT1A1 Regulatory Variant with Potential Effect on Efficacy of HIV and Cancer Drugs Commonly Prescribed in South Africa	2
Pharmacogenetic Testing in Psychiatry and Neurology: an Overview of Reviews	2

Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention	2
Effect of OPRM1/COMT Gene Polymorphisms on Sufentanil Labor Analgesia: A Cohort Study Based on Propensity Score Matching	2
Pharmacogenomic curriculum in Australian medical schools: a content analysis study	2
Opportunity for Pharmacogenetics Testing in Patients with Sickle Cell Anemia	2
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease	2
Genetic Factors in Treatment-Related Cardiovascular Complications in Survivors of Childhood Acute Lymphoblastic Leukemia	1
Building an Information System to Facilitate Pharmacogenomics Clinical Translation with Clinical Decision Support	1
Parental Understanding and Attitudes Following Pharmacogenomic Testing for Pediatric Neuropsychiatric Patients	1
Pharmacogenomics Education, Research and Clinical Implementation in the State of Minnesota	1
The Need to Shift Pharmacogenetic Research from Candidate Gene to Genome-Wide Association Studies	1
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma	1
HLA-B*57:01 Typing in a Malaysian Cohort: Implications of Abacavir Hypersensitivity in People Living with HIV	1
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management	1
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide	1
ARG2 Single-Nucleotide Polymorphism RS3742879 Affects Plasma Arginase 2 Levels, Nitric Oxide Formation and Antihypertensive Therapy Response in Preeclampsia	1
Pharmacogenomics of Oxcarbazepine in the Treatment of Epilepsy	1
Pharmacogenetics Studies in Stroke Patients Treated with rtPA: a Review of the Most Interesting Findings	1
Association of Polymorphisms in ARRB2 and Clinical Response to Methadone for Pain in Advanced Cancer	1
SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate	1
Frequency and Impact of DHODH, ABCG2 and CYP2C19 SNPs on the Therapeutic Efficacy, Tolerability and Toxicity of Leflunomide	1
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice	1
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review	1
Leveraging Clinical Decision Support to Reduce the Risk of Discordant Pharmacogenomics Results	1
TPMT Gene Polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a Healthy Venezuelan Population	1
Methods for Actionable Gene Fusion Detection in Lung Cancer: Now and in the Future	1
Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine	1
Engaging Pharmacogenomics in Pain Management and Opioid Selection	1
Warfarin Pharmacogenetics in a Black Zimbabwean Cohort: An Observational Prospective Study	1
Adolescent Perceptions of Pharmacogenetic Testing	1
Antiplatelet Therapy Guided by CYP2C19 Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions	1
Single-Nucleotide Polymorphisms in ABC Drug Transporters Alter Expression and Circulating Tenofovir in Healthy South African Women Exposed to Pre-Exposure Prophylaxis	1
Psychiatric Level 1A Evidence Pharmacogenomics in a Brazilian Admixed Cohort and Global Populations	1
Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients	1
HLA-DRB1 *16:02 is Associated with PEG-Asparaginase Hypersensitivity	1
Pharmacogenetic and Pharmacogenomic Treatment of Rheumatoid Arthritis: A Review of Pharmacogenomics Knowledge Base Scientific Evidence	1
Pharmacogenetics of HIV Therapy: Challenges for Tailoring Treatment in Genetically Complex Populations	1
Differential Correlation Network Analysis of Rectal Transcriptomes Reveals Cystic Fibrosis-Related Disturbance	1
Potential association of SULT2A1 and ABCG2 variant alleles with increased risk for palbociclib toxicity	1
Congruence Rates for Pharmacogenomic Noninterruptive Alerts	1
Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey	1
Identifying Genetic Modulators of Statin Response Using Subject-Derived Lymphoblastoid Cell Lines	1
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population	1
Substrate Specificity of CYP2D6 Genetic Variants	1
An Interview with Dr Chiara Fabbri: Pharmacogenomics and Drug Repurposing for Treatment-Resistant Depression	1
Capecitabine-Induced Enterocolitis: A Case Report and Pharmacogenetic Profile	1
Relevance of NAT2 Genotype and Clinical Factors to Risk for Antituberculosis Drug-Induced Liver Injury	1
Inaugural Pharmacogenomics Access and Reimbursement Symposium	1
The Role of Alcohol Intake in the Pharmacogenetics of Treatment with Clozapine	1
Pharmacogenomics of Hydroxyurea Therapy and Fetal Hemoglobin Levels in Sickle Cell Anemia	1
Identification of Clinical and Pharmacogenetic Factors Influencing Metformin Response in Type 2 Diabetes Mellitus	1
Pharmacogenetic Loci for Rosuvastatin are Associated with Intima-Media Thickness Change and Coronary Artery Disease Risk	1
Ethnic differences in pharmacogenomic variants: a south Asian perspective	1
Detection of Relevant Pharmacogenetic Information Through Exome Sequencing in Oncology	1
Gender-Dependent Association of Tyms -TSER Polymorphism With 5-Fluorouracil or Capecitabine-Based Chemotherapy Toxicity	1
It is time for educators to act: pharmacogenomics education and its implementation into clinical practice	1
Evaluation of a Longitudinal Pharmacogenomics Education on Pharmacist Knowledge in a Multicampus Healthcare System	1
Artificial intelligence, medications, pharmacogenomics, and ethics	1
NAMPT Single-Nucleotide Polymorphism rs1319501 and Visfatin/NAMPT Affect Nitric Oxide Formation, sFlt-1 and Antihypertensive Therapy Response in Preeclampsia	1
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety	1
The Need for Further Studies Examining the Role of Endothelial Nitric Oxide Synthase Polymorphisms in Drug Response	1